[1] 温莉虹,林瑞泼,陈阿德,等.CD117和SOX10在恶性黑色素瘤中的表达及意义[J].温州医科大学学报,2017,47(3):197-200.
[2] KOZOVSKA Z,GABRISOVA V,KUCEROVA L.Malignant melanoma:diagnosis,treatment and cancer stem cells[J].Neoplasma,2016,63(4):510-517.
[3] 赵滨,阴亚坤.皮肤黑色素瘤中PITX1表达及其与临床病例特征和预后的关系[J].中国中西医结合皮肤性病学杂志,2020,19(1):20-24.
[4] MCNEAL A S,LIU K,NAKHATE V,et al.CDKN2B loss promotes progression from benign melanocytic nevus to melanoma[J].Cancer Discovery,2015,5(10):1072.
[5] 文博,谭谦.皮肤黑色素瘤一线治疗研究进展[J/OL].东南大学学报(医学版),2018,37(3):524-529.
[6] 梁宝磊,魏豪,石柯,等.NF-κB信号通路在胸外科常见恶性肿瘤中的研究进展[J/OL].中华胸部外科电子杂志,2019,6(4):253-257.
[7] 姜一弘,张丹,张天择,等.核因子κB(NF-κB)信号通路在炎症与肿瘤中作用的研究进展[J].细胞与分子免疫学杂志,2018,34(12):1130-1135.
[8] DONIGAN J M,De LUCA J,LUM C.Cyclin D1 and p16 expression in blue nevi and malignant melanoma[J].Appl Immunohistochem Mol Morphol,2017,25(2):91-94.
[9] KAROLINE K,CORALIE B,FLORIAN B,et al.The interplay of CDK4 and CDK6 in melanoma[J].Oncotarget,2019,10(14):1346-1359.
[10] ETHIKA T,BIN L,CHELSEA L,et al.Loss of p16INK4A stimulates aberrant mitochondrial biogenesis through a CDK4/Rb-independent pathway[J].Oncotarget,2017,8(34):55848-55862.
[11] 吕青,张恋茹,季留连,等.74例皮肤黑色素瘤的预后及影响因素分析[J].临床肿瘤学杂志,2017,22(3):249-254.
[12] 陈花花,吕大伦,虞佳其,等.皮肤恶性黑色素瘤患者预后的影响因素分析[J].癌症进展,2019,17(8):936-938.
[13] 付冉,王艳林,黄利鸣.P16表达异常与肿瘤关系的研究进展[J].生命的化学,2017,37(4):585-589.
[14] MALGORZATA M W,PATRYCJA C,VIOLETTA F,et al.Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the polish population[J]Postepy Dermatol Alergol,2017,34(5):490-498.
[15] TSCHANDL P,BERGHOFF A S,PREUSSER M,et al.Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and nevi in vivo[J].British J Dermat,2015,174(2):364-370.
[16] JUNG-SOO P,EUN-KYUNG K.Clinicopathological significance and prognostic implication of nuclear factor-κB activation in colorectal cancer[J].Pathol Res Pract,2019,215(8):152469.
[17] 王骞,谭林,陈维顺.Rspo1、LGR5、NF-κB/P65在胃癌中的表达及其临床意义[J].中国组织化学与细胞化学杂志,2019,28(5):436-442.
[18] SANKI A,LI W,COLMAN M,et al.Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma[J].Pathology,2007,39(6):551-557.
[19] 吴晓雯,闫君雅,代杰,等.中国134例黑色素瘤患者P16INK4a、CDK4和CCND1基因突变及其临床意义[J].基础医学与临床,2018,38(2):153-157.
[20] CHEN H B,LI Y Y,LONG Y,et al.Increased p16 and p53 protein expression predicts poor prognosis in mucosal melanoma[J].Oncotarget,2017,8(32):53226-53233. |